What are the favorable results of the seventh batch of national drug collection?

31 treatment category

60 kinds of drug procurement successfully

Average price reduction 48%

Native

recently

The seventh batch of national organization drugs

The results of the concentrated with volume procurement are released

What benefits will it bring to patients?

Since 2018, my country has carried out 7 batches of national drug collection, covering a total of 294 kinds of drugs, with an average decrease of drug prices exceeding 50%. It will save 18.5 billion yuan.

In this national collection, the coverage of drugs has been further expanded, and the price of drug prices is more rational. At the same time, it introduces the mechanism of providing corporates and implements a "inter -grade melting".

The amount of water is replaced with amount of water, and the price of medicine is "slimming" to reduce the burden on patients. This is just a side of the collection of medicines. The price of "one medicine" involves the various interests of patients, enterprises, hospitals, and medical insurance funds.

Behind the degradation

The decline in drug prices directly affects the "money bag" of patients. Each national drug "group purchase", the decreased figures have attracted much attention. Compared with the average decline of 53%of the national drug collection prices of 53%, the average decrease of 48%of this episode is relatively milder.

Jiang Changsong, assistant to the dean of the National Medical Security Research Institute and director of the price recruitment room, said that on the one hand, after multiple rounds of collection, the quotation has been rational, and the variety of "floor prices" is increasing. Loen the reasonable profit and expectations; on the other hand, the inter -provincial alliances, regional alliances, and provinces have been developed separately. After being squeezed once, the price reduction space is naturally not large.

In this regard, Yao Yu, deputy director of the Cultural Bearing Laboratory of the Chinese Academy of Social Sciences and a professor at the School of Economics of the University of China, also expressed a similar point of view. "Some selected medicines in the collection are not necessarily produced by this factory, and may be produced by foundry, so potential risks such as rising raw materials and rising foundry costs are needed. The phenomenon of confession needs to leave enough price space for enterprises.

In the opinion of the interviewed experts, Ji Cai is to allow the majority of patients to buy good medicines for consistent evaluation at a lower price, but it is not blindly reduced the price, but to achieve patients, medical insurance funds, pharmaceutical companies, and hospitals. Win -win. It is foreseeable that after the water of multiple rounds of mini -priced prices is squeezed out, the price reduction of the future collection will be weakened. The raw materials, technology, and manpower required for generic drug production will become the decisive factor of price.

"One province double supply" guarantees drug supply

This time the collection of drugs involved 31 treatment categories, which not only includes common diseases and chronic diseases such as hypertension, diabetes, anti -infection, digestive tract diseases, etc., but also major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer. obvious.

Among them, taking the first -line liver cancer -targeted Yaolunbutoni capsule as an example, each decreased from an average of 108 yuan to an average of 18 yuan, and a treatment cycle can save 8,100 yuan. In the field of lowering blood pressure, for the first time, it was included in the slow -controlled release. Anti -virus drug Oasievil, which treats influenza, reduced from average 4.5 yuan to 1 yuan each.

During the interview, many patients with hypertension mentioned to reporters that after the price of drug prices was "slimming", the cost of medicine saved a lot, and hoped that the supply of medicines would be more guaranteed. The reporter found out that due to various reasons, there were indeed in the previous rounds of the selection of companies in some regions.

It is precisely to ensure the stable supply of integrated drugs that this time the collection is introduced to the corporate mechanism for the first time to explore the realization of "one province and double supply".

Specifically, each province not only has one of the Chinese selected enterprises, that is, the main company, but also one for the company. The selected varieties in the middle of the selected enterprises cannot be supplied in a timely manner or canceled the qualifications of the selection. As a result, when the agreement cannot continue to be fulfilled, the province's alternative enterprise will supply the corresponding selection varieties, which is equivalent to the stable supply of the collection varieties. In Yao Yu's opinion, the preparation of corporate mechanisms will also put some pressure on the bidders and urge them to better complete the supply indicator.

In addition, in order to avoid the phenomenon of the price of high school bids for empty speculation, this collection also introduced the "inter -tie melting" rules, comparing the spread of different varieties at the same level, and effectively controlled the difference in the price difference of the selected products. At about 3 times.

Open the "last mile"

After the drug collection is squeezed off the water, the patient wants to buy and use the collection of medicines, depend on the "last mile" of the collection of the land -hospital and doctor.

Wang Jia (a pseudonym) of the doctor of the Pharmaceutical Department of a Trina Hospital in Beijing told reporters that after the state launched the collection, her responsibilities with colleagues had more content Selected medicines are preferred, and the reasonable needs of patients should be guaranteed.

According to data from the State Medical Insurance Bureau, 7 batches of collection have accounted for 35%of the annual cost of medical institutions, and centralized procurement has become an important model for drug procurement in medical institutions.

Wang Jia admits that there are indeed some patients who have the mentality of "one point price and one point". They are worried that after the price of drug prices declines, the quality is not guaranteed. "This requires the hospital to introduce the collection policy to the patient, explaining that the state has very strict requirements for the quality and efficacy of shortlisted drugs, so that patients are voluntarily replaced by use."

Jiang Changsong said that after the collection of medicines, at least 80%to 90%of the universal names of the medicine passed the one -time evaluation of the drug supervision department.Hyd sex."After the collection, the medicine is cheap, but patients cannot use it casually." Wang Jia said that with the implementation of the drug collection, drugs need to strengthen management and ensure standardized drug use in clinical use to prevent drug abuse.

Earlier, the National Medical Insurance Administration stated that it would guide relevant departments to the implementation of the results of the selection of the middle school and the elected enterprises in conjunction with relevant departments to ensure that patients across the country used the selected products after this collection of prices in November this year.As of now, the seventh batch of the seventh batch of collection of collection and landing in Guangdong and Tianjin provinces.

Source ｜ Workers' Daily People's Daily

Chengdu Published Edit ｜ Tian Dou

- END -